Bacillus Calmette-Guerin Infection in NADPH Oxidase Deficiency: Defective Mycobacterial Sequestration and Granuloma Formation

PLoS Pathogens

Volumn 10, Issue 9, 2014, Pages

  Deffert, Christine ^a   Schäppi, Michela G ^a   Pache, Jean Claude ^a   Cachat, Julien ^a   Vesin, Dominique ^a   Bisig, Ruth ^a   Ma Mulone, Xiaojuan ^a   Kelkka, Tiina ^b,c   Holmdahl, Rikard ^b,c   Garcia, Irene ^a   Olleros, Maria L ^a   Krause, Karl Heinz ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b UNIVERSITY OF TURKU   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ACID PHOSPHATASE; CXCL1 CHEMOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 17; NITRIC OXIDE; RANTES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TUMOR NECROSIS FACTOR ALPHA; 3-NITROTYROSINE; CYTOKINE; NOS2 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL LOAD; CELL ISOLATION; CFU COUNTING; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; ENZYME DEFICIENCY; GENE EXPRESSION; HEMORRHAGIC PNEUMONIA; HISTOLOGY; MACROPHAGE; MOUSE; MUTATION; MYCOBACTERIOSIS; MYCOBACTERIUM BOVIS BCG; NONHUMAN; PNEUMONIA; SPLEEN CELL; WEIGHT REDUCTION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; FEMALE; GRANULOMA; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY;

MYCOBACTERIUM BOVIS BCG;

ANIMALS; CYTOKINES; FEMALE; GRANULOMA; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; NADPH OXIDASE; NITRIC OXIDE SYNTHASE TYPE II; REACTIVE OXYGEN SPECIES; TYROSINE;

EID: 84907572338     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004325     Document Type: Article

References (54)

1. Andersen P, Doherty TM, (2005) The success and failure of BCG - implications for a novel tuberculosis vaccine. Nat Rev Microbiol 3: 656–662.
2. Keijsers RR, Bovenschen HJ, Seyger MM, (2011) Cutaneous complication after BCG vaccination: case report and review of the literature. J Dermatolog Treat 22: 315–318.
3. Bustamante J, Picard C, Boisson-Dupuis S, Abel L, Casanova JL, (2011) Genetic lessons learned from X-linked Mendelian susceptibility to mycobacterial diseases. Ann N Y Acad Sci 1246: 92–101.
4. van der Meijden AP, Steerenberg PA, de Jong WH, Debruyne FM, (1991) Intravesical Bacillus Calmette-Guerin treatment for superficial bladder cancer: results after 15 years of experience. Anticancer research 11: 1253–1258.
5. Steg A, Leleu C, Debre B, Boccon-Gibod L, Sicard D, (1989) Systemic bacillus Calmette-Guerin infection, ‘BCGitis’, in patients treated by intravesical bacillus Calmette-Guerin therapy for bladder cancer. Eur Urol 16: 161–164.
6. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, et al. (2007) BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol 120: 32–38.
7. Li HM, Zhao SY, He JX, Jiang ZF, (2010) [Clinical analysis of 18 children with disseminated Bacille Calmette-Guerin infection]. Zhonghua Er Ke Za Zhi 48: 65–68.
8. Ying WJ, Wang XC, Sun JQ, Liu DR, Yu YH, et al. (2012) [Clinical features of chronic granulomatous disease]. Zhonghua Er Ke Za Zhi 50: 380–385.
9. Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N, (2012) Bacillus Calmette-Guerin (BCG) complications associated with primary immunodeficiency diseases. J Infect 64: 543–554.
10. Fattahi F, Badalzadeh M, Sedighipour L, Movahedi M, Fazlollahi MR, et al. (2011) Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J Clin Immunol 31: 792–801.
11. Bedard K, Krause KH, (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245–313.
12. Schappi M, Deffert C, Fiette L, Gavazzi G, Herrmann F, et al. (2008) Branched fungal beta-glucan causes hyperinflammation and necrosis in phagocyte NADPH oxidase-deficient mice. J Pathol 214: 434–444.
13. Nathan C, Shiloh MU, (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 97: 8841–8848.
14. Deffert C, Cachat J, Krause KH, (2014) Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections. Cell Microbiol 16: 1168–1178.
15. Garcia I, Olleros ML (2009) The roles of tumor necrosis factor and other macrophage-derived cytokines in host defense mechanisms during the course of Mycobacterium tuberculosis infection. In: Current Topics on the Profiles of Host Immunological Response to Mycobacterial Infections pp. 1–46.
16. Garcia I, Olleros ML, Quesniaux VF, Jacobs M, Allie N, et al. (2011) Roles of soluble and membrane TNF and related ligands in mycobacterial infections: effects of selective and non-selective TNF inhibitors during infection. Adv Exp Med Biol 691: 187–201.
17. Lowe DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR, (2012) Neutrophils in tuberculosis: friend or foe? Trends Immunol 33: 14–25.
18. Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, et al. (2011) Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol 12: 213–221.
19. Koker MY, Camcioglu Y, van Leeuwen K, Kilic SS, Barlan I, et al. (2013) Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol 132: 1156–1163 e1155.
20. Lee WI, Huang JL, Yeh KW, Jaing TH, Lin TY, et al. (2011) Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs). J Formos Med Assoc 110: 750–758.
21. Lin CJ, Wang SC, Ku CL, Kao JK, Chen M, et al. (2013) Successful Unrelated Cord Blood Stem Cell Transplantation in an X-linked Chronic Granulomatous Disease Patient with Disseminated BCG-induced Infection. Pediatr Neonatol DOI: 10.1016/j.pedneo.2013.04.001
22. Khotaei G, Hirbod-Mobarakeh A, Amirkashani D, Manafi F, Rezaei N, (2012) Mycobacterium tuberculosis meningitis as the first presentation of chronic granulomatous disease. Braz J Infect Dis 16: 491–492.
23. Naidoo R, Jordaan N, Chan KW, Le Roux DM, Pienaar S, et al. (2011) A novel CYBB mutation with the first genetically confirmed case of chronic granulomatous disease in South Africa. S Afr Med J 101: 768–769.
24. Afshar Paiman S, Siadati A, Mamishi S, Tabatabaie P, Khotaee G, (2006) Disseminated Mycobacterium bovis infection after BCG vaccination. Iran J Allergy Asthma Immunol 5: 133–137.
25. Lee PP, Chan KW, Jiang L, Chen T, Li C, et al. (2008) Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J 27: 224–230.
26. Sadeghi-Shanbestari M, Ansarin K, Maljaei SH, Rafeey M, Pezeshki Z, et al. (2009) Immunologic aspects of patients with disseminated bacille Calmette-Guerin disease in north-west of Iran. Ital J Pediatr 35: 42.
27. Kusuhara K, Ohga S, Hoshina T, Saito M, Sasaki Y, et al. (2009) Disseminated Bacillus Calmette-Guerin lymphadenitis in a patient with gp91phox- chronic granulomatous disease 25 years after vaccination. Eur J Pediatr 168: 745–747.
28. Movahedi Z, Norouzi S, Mamishi S, Rezaei N, (2011) BCGiosis as a presenting feature of a child with chronic granulomatous disease. Braz J Infect Dis 15: 83–86.
29. Deffert C, Carnesecchi S, Yuan H, Rougemont AL, Kelkka T, et al. (2012) Hyperinflammation of chronic granulomatous disease is abolished by NOX2 reconstitution in macrophages and dendritic cells. J Pathol 228: 341–350.
30. Sareila O, Jaakkola N, Olofsson P, Kelkka T, Holmdahl R, (2013) Identification of a region in p47phox/NCF1 crucial for phagocytic NADPH oxidase (NOX2) activation. J Leukoc Biol 93: 427–435.
31. Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, et al. (2007) Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 117: 3020–3028.
32. Pizzolla A, Hultqvist M, Nilson B, Grimm MJ, Eneljung T, et al. (2012) Reactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections. J Immunol 188: 5003–5011.
33. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC, (1997) Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med 185: 207–218.
34. Garcia I, Guler R, Vesin D, Olleros ML, Vassalli P, et al. (2000) Lethal Mycobacterium bovis Bacillus Calmette Guerin infection in nitric oxide synthase 2-deficient mice: cell-mediated immunity requires nitric oxide synthase 2. Lab Invest 80: 1385–1397.
35. Pacher P, Beckman JS, Liaudet L, (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315–424.
36. Chtanova T, Schaeffer M, Han SJ, van Dooren GG, Nollmann M, et al. (2008) Dynamics of neutrophil migration in lymph nodes during infection. Immunity 29: 487–496.
37. Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G, (2010) CCL5 participates in early protection against Mycobacterium tuberculosis. J Leukoc Biol 87: 1153–1165.
38. Breen AP, Murphy JA, (1995) Reactions of oxyl radicals with DNA. Free Radic Biol Med 18: 1033–1077.
39. Sanmun D, Witasp E, Jitkaew S, Tyurina YY, Kagan VE, et al. (2009) Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: implications for chronic granulomatous disease. Am J Physiol Cell Physiol 297: C621–631.
40. von Kockritz-Blickwede M, Nizet V, (2009) Innate immunity turned inside-out: antimicrobial defense by phagocyte extracellular traps. J Mol Med (Berl) 87: 775–783.
41. Bianchi M, Niemiec MJ, Siler U, Urban CF, Reichenbach J, (2011) Restoration of anti-Aspergillus defense by neutrophil extracellular traps in human chronic granulomatous disease after gene therapy is calprotectin-dependent. J Allergy Clin Immunol 127: 1243–1252 e1247.
42. Hatanaka E, Carvalho BT, Condino-Neto A, Campa A, (2004) Hyperresponsiveness of neutrophils from gp 91phox deficient patients to lipopolysaccharide and serum amyloid A. Immunol Lett 94: 43–46.
43. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, et al. (2004) Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci U S A 101: 12646–12651.
44. Hanus M, Matouskova M, Verner P, Hyrsl L, (1994) Immunotherapy of superficial bladder tumors: preliminary results with ImmuCyst–BCG Connaught, Toronto. Neoplasma 41: 25–27.
45. Olleros ML, Vesin D, Bisig R, Santiago-Raber ML, Schuepbach-Mallepell S, et al. (2012) Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules. PLoS One 7: e31469.
46. Olleros ML, Guler R, Corazza N, Vesin D, Eugster HP, et al. (2002) Transmembrane TNF induces an efficient cell-mediated immunity and resistance to Mycobacterium bovis bacillus Calmette-Guerin infection in the absence of secreted TNF and lymphotoxin-alpha. J Immunol 168: 3394–3401.
47. Olleros ML, Guler R, Vesin D, Parapanov R, Marchal G, et al. (2005) Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections. Am J Pathol 166: 1109–1120.
48. Fotio AL, Olleros ML, Vesin D, Tauzin S, Bisig R, et al. (2010) In vitro inhibition of lipopolysaccharide and mycobacterium bovis bacillus Calmette Guerin-induced inflammatory cytokines and in vivo protection from D-galactosamine/LPS -mediated liver injury by the medicinal plant Sclerocarya birrea. Int J Immunopathol Pharmacol 23: 61–72.
49. Bedard K, Attar H, Bonnefont J, Jaquet V, Borel C, et al. (2009) Three common polymorphisms in the CYBA gene form a haplotype associated with decreased ROS generation. Hum Mutat 30: 1123–1133.
50. Guler R, Olleros ML, Vesin D, Parapanov R, Vesin C, et al. (2004) Inhibition of inducible nitric oxide synthase protects against liver injury induced by mycobacterial infection and endotoxins. J Hepatol 41: 773–781.
51. Guler R, Olleros ML, Vesin D, Parapanov R, Garcia I, (2005) Differential effects of total and partial neutralization of tumor necrosis factor on cell-mediated immunity to Mycobacterium bovis BCG infection. Infect Immun 73: 3668–3676.
52. Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, et al. (2009) Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 66: 384–392.
53. Vigne S, Palmer G, Martin P, Lamacchia C, Strebel D, et al. (2012) IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells. Blood 120: 3478–3487.
54. Deffert C, Olleros ML, Huiping Y, Herrmann FR, Zekry D, et al. (2011) TNF-alpha blockade in chronic granulomatous disease-induced hyperinflammation: patient analysis and murine model. J Allergy Clin Immunol 128: 675–677.